reading discontinuation threads from 2024 and half of it aged badly
reading discontinuation threads from 2024 and half of it aged badly. Not a hot take, just something I have not seen said plainly here.
With a week-long half-life, exposure declines over several weeks after the last dose rather than stopping with it. The lag is why the first fortnight is uninformative.
Preparing to stop, as described by people here who have done it.
Write down where you are first: dose, date, weight, waist, and an honest note about how appetite feels. That page is what makes the following six months interpretable rather than a fog of impressions.
Decide in advance what you are watching for and over what period — appetite in the first month, weight over three, and a specific threshold at which you would want to revisit the decision. Have the conversation with a clinician before rather than after.
None of that is a schedule. It is a way of arriving at whatever happens next with information rather than with a vague sense of how it is going.
Why the first fortnight tells you nothing.
With a week-long half-life, exposure declines over several weeks after a final dose rather than ending with it. So the first two weeks after stopping are still a tail of the previous state, and the stability people report in that window is not evidence about the months after it.
The reports here are fairly consistent: appetite noticeably different somewhere in the second month, weight following later, and the trajectory strongly influenced by whether the habits from the losing phase survived. That is not a prediction for anybody in particular, and it is not a schedule — it is the shape of what members describe, which is the most this board can honestly offer.
Sceptical readings welcome. The confident ones are the ones I distrust.
best — the order this archive was captured in
Interval stretching lowers the trough concentration while keeping the dose; dose reduction lowers the level while keeping the rhythm. They are different interventions with different subjective profiles.
Interval stretching lowers the trough concentration while keeping the dose; dose reduction lowers the level while keeping the rhythm.
Agreed — and the exposure lag means the first fortnight tells you almost nothing.
Has appetite changed yet, independent of the scale?
Left up. It is honest about the reason for stopping and about the timeline.
Went back on after eight months away. Nobody here made me feel bad about it, which mattered more than I expected.
Withdrawal studies across this class consistently show substantial regain after discontinuation, with appetite typically returning before weight changes. That is a description of the pharmacology of a chronic condition.
There is very little published guidance on stopping specifically, which is exactly why board consensus here should carry less weight than usual and a clinician conversation should carry more.
interval stretching is the most commonly described approach here
I would not treat appetite returning as a sign of doing it wrong. It is the expected sequence.
How long were you at the dose you are coming off?
Cosigning that cost and supply are legitimate reasons. Most of the stopping threads here are one of those two.